[Breaking] Samcheondang Pharm Turns Lower in Regular Session... Volatility Expands as VI Triggered Twice

Samcheondang Pharmaceutical (000250) exhibited significant volatility early in the session on the 21st, with the Volatility Interruption (VI) mechanism triggered twice. While the stock showed strength in the pre-market alternative trading system (NXT), it turned lower after the regular session opened, failing to extend the previous day's upward momentum that ended in a daily limit gain.

As of 9:05 a.m. on this day, Samcheondang Pharmaceutical is trading at 217,500 won, down 21,500 won (9.00%) from the previous trading day.

The VI was triggered consecutively before and after the market open. In the pre-market NXT, it was triggered at 8:00 a.m. and lifted at 8:02 a.m. In the regular session, it was triggered again at 9:01:54 a.m. and lifted at 9:03:57 a.m. This is interpreted as an indication of high volatility, with strong buying and selling forces clashing immediately after the market opened.

Samcheondang Pharmaceutical drew strong buying interest in the pre-market NXT and showed an upward trend, but turned lower after the regular session opened as profit-taking sell orders emerged. Having hit the daily limit the previous day, the stock continues to see trading battles amid a short-term surge.

At the same time, the domestic stock market is mixed. The KOSPI is hovering in slightly negative territory around the 6,510 level, while the KOSDAQ index is down more than 1% around the 740 level, reflecting a somewhat subdued investor sentiment.

As Samcheondang Pharmaceutical continues to exhibit high volatility following its short-term surge, investor attention is expected to focus on intraday supply and demand changes, the possibility of additional VI triggers, and the stock's trajectory in the afternoon session.

[※ This article is based on market trends and is not intended to recommend or solicit the purchase or sale of any specific stock. Investment decisions and responsibilities lie solely with the investor.]